Ameriabank’s retail loan portfolio stands at 18 billion drams

YEREVAN, December 9. /ARKA/. Ameriabank’s retail loan portfolio stands now at 18 billion drams, Vazrik Sekoyan, head of its retail banking department said today.

“Today, the share of retail loans in our overall loan portfolio make 15%. Under our business plan we plan to increase it this year up to 25-30%,” he told reporters on Friday.

Sekoyan said the bank will announce a string of discounts on different products at different periods of times.

“We have launched three new mortgage products, which will be offered with discounts,’ he said.

Ameriabank is a universal bank offering investment, corporate and retain banking services. It is owned by Troika Dialogue, one of the largest Russian investment companies. ($1 – 383.54 drams). -0-

spot_img

POPULAR

“Solis” CJSC’s bonds listed on Armenia Stock Exchange

YEREVAN, August 18. /ARKA/. The range of companies listed on the Armenia Stock Exchange (AMX) continues to expand, contributing to the development of the capital market and creating new opportunities for businesses.

Armenian dram strengthens against US dollar and weakens against euro and ruble

YEREVAN, August 21. /ARKA/. The average market exchange rate of the US dollar to the Armenian dram on the Armenian foreign exchange market on August 21, 2026, fell by 0.1 point to 365.16 drams compared to August 20.

New requirements for banks to manage risks of circumventing international sanctions come into effect in Armenia

YEREVAN, August 17. /ARКА/. As of August 12, 2026, new regulations for banks regarding the management of risks associated with evading international sanctions have been implemented in Armenia.

Acba Bank has issued over 1 million cards, solidifying its leadership in Armenia

YEREVAN, August 17. /ARKA/. For more than five years, Acba Bank has held the top spot in the Armenian card market. As of May 2026, the total number of cards issued by the bank surpassed 1 million, as reported by the bank's press service.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img